Publication: Reuters
Abstract
AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in alignment with FDA initiatives to reduce animal testing. Read this Reuters article to learn how cutting back on animal testing by using AI technology can save the pharmaceutical industry time and money.
Published: September 2, 2025
Services
Solutions
Are you prepared for the FDA’s phase out of animal tests for mAbs?
This webinar will explain how new approach methodologies (NAMs), including in silico tools and computational modeling, can be integrated into your drug development programs to align with the FDA Roadmap to phase out animal tests.
